Showing results (421-430 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|October 6, 2018
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsLuz M Canet, Jose M Sánchez-Maldonado, Rafael Cáliz, et al.
The Pharmacogenomics Journal|March 23, 2022
A systematic review on the cost effectiveness of pharmacogenomics in developing countries: implementation challengesAsif Sukri, Mohd Zaki Salleh, Collen Masimirembwa, et al.
The Pharmacogenomics Journal|January 13, 2006
The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabineR Hermann, J Borlak, U Munzel, et al.
The Pharmacogenomics Journal|January 13, 2006
Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependenceJ P Dahl, C Jepson, R Levenson, et al.
The Pharmacogenomics Journal|February 1, 2006
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's diseaseM E Risner, A M Saunders, J F B Altman, et al.
The Pharmacogenomics Journal|June 10, 2009
Association of genotypes of the CYP3A cluster with midazolam disposition in vivoJ Miao, Y Jin, R L Marunde, et al.
The Pharmacogenomics Journal|February 25, 2009
Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patientsC C Zai, A K Tiwari, V Basile, et al.
The Pharmacogenomics Journal|June 17, 2009
APOE gene polymorphisms and response to statin therapyE Zintzaras, G D Kitsios, F Triposkiadis, et al.
The Pharmacogenomics Journal|September 16, 2009
Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimusMateusz Kurzawski, Krzysztof Dziewanowski, Karolina Kedzierska, et al.
The Pharmacogenomics Journal|September 16, 2009
MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcomeM Cizmarikova, M Wagnerova, L Schonova, et al.
Pageof 135